Clinical Trial Update: A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mg [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 bioequivalence crossover study comparing Glucobay ODT 100 mg with Glucobay standard tablet 100 mg in Type 2 diab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glucobay ODT 100 mg (acarbose)
• Glucobay Standard Tablet 100 mg (acarbose)

Snippet

Sponsor: Bayer | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED